Characteristics Associated With Differences in Survival Among Black and White Women With Breast Cancer

Authors: Silber, Jeffrey H., Rosenbaum, Paul R., Clark, Amy S., Giantonio, Bruce J., Ross, Richard N., Teng, Yun, Wang, Min, Niknam, Bijan A., Ludwig, Justin M., Wang, Wei, Even-Shoshan, Orit, Fox, Kevin R.

Source: Silber, Jeffrey H. and Rosenbaum, Paul R. and Clark, Amy S. and Giantonio, Bruce J. and Ross, Richard N. and Teng, Yun and Wang, Min and Niknam, Bijan A. and Ludwig, Justin M. and Wang, Wei and Even-Shoshan, Orit and Fox, Kevin R. (2013) Characteristics Associated With Differences in Survival Among Black and White Women With Breast Cancer. The Journal of the American Medical Association , 310 (4). pp. 389-397.

File Description: application/pdf

Relation: http://health-equity.pitt.edu/4150/

Summary: Appropriate Use Criteria for Estrogen Receptor—Targeted PET Imaging with 16α-^1^8F-Fluoro-17β-Fluoroestradiol

Authors: Ulaner, Gary A., Mankoff, David A., Clark, Amy S., Fowler, Amy M., Linden, Hannah M., Peterson, Lanell M., Dehdashti, Farrokh, Kurland, Brenda F., Mortimer, Joanne, Mouabbi, Jason

Source: Journal of nuclear medicine. 64(3):351-354

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632772670&indx=1&recIds=ETOCRN632772670

Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer

Authors: Ulaner, Gary A., Fowler, Amy M., Clark, Amy S., Linden, Hannah

Source: In PET Clinics October 2023 18(4):531-542

16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography to Measure Regional Estrogen Receptor Expression in Breast Cancer

Authors: Mankoff, David A., Clark, Amy S., Edmonds, Christine E., O'Brien, Sophia R., Pantel, Austin R.

Source: Journal of clinical oncology. 40(31):3660-3663

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173118748.0x000001&indx=1&recIds=ETOCvdc_100173118748.0x000001

Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States

Authors: Parikh, Ravi B, Takvorian, Samuel U, Vader, Daniel, Paul Wileyto, E, Clark, Amy S, Lee, Daniel J, Goyal, Gaurav, Rocque, Gabrielle B, Dotan, Efrat, Geynisman, Daniel M, Phull, Pooja, Spiess, Philippe E, Kim, Roger Y, Davidoff, Amy J, Gross, Cary P, Neparidze, Natalia, Miksad, Rebecca A, Calip, Gregory S, Hearn, Caleb M, Ferrell, Will, Shulman, Lawrence N, Mamtani, Ronac, Hubbard, Rebecca A

Source: Journal of the National Cancer Institute. 114(4):571-578

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100146760086.0x000001&indx=1&recIds=ETOCvdc_100146760086.0x000001

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

Authors: Adamson, Kathi, Albain, Kathy S., Asare, Adam L., Asare, Smita M., Balassanian, Ron, Beckwith, Heather, Berry, Scott M., Berry, Donald A., Boughey, Judy C., Buxton, Meredith B., Chen, Yunn-Yi, Chen, Beiyun, Chien, A. Jo, Chui, Stephen Y., Clark, Amy S., Clennell, Julia L., Datnow, Brian, DeMichele, Angela M., Duan, Xiuzhen, Edmiston, Kirsten K., Elias, Anthony D., Ellis, Erin D., Esserman, Laura L., Euhus, David M., Fadare, Oluwole, Fan, Fang, Feldman, Michael D, Forero-Torres, Andres, Haley, Barbara B., Han, Hyo S., Harada, Shuko, Haugen, Patricia, Helsten, Teresa, Hirst, Gillian L., Hylton, Nola M., Isaacs, Claudine, Kemmer, Kathleen, Khan, Qamar J., Khazai, Laila, Klein, Molly E., Krings, Gregor, Lang, Julie E., LeBeau, Lauren G., Leyland-Jones, Brian, Liu, Minetta C., Lo, Shelly, Lu, Janice, Magliocco, Anthony, Matthews, Jeffrey B., Melisko, Michelle E., Mhawech-Fauceglia, Paulette, Moulder, Stacy L., Murthy, Rashmi K., Nanda, Rita, Northfelt, Donald W., Ocal, Idris T., Olopade, Olufunmilayo, Pambuccian, Stefan, Paoloni, Melissa, Park, John W., Parker, Barbara A., Perlmutter, Jane, Peterson, Garry, Pusztai, Lajos, Rendi, Mara, Rugo, Hope S., Sahoo, Sunati, Sams, Sharon, Sanil, Ashish, Sattar, Husain, Schwab, Richard B., Singhrao, Ruby, Steeg, Katherine, Stringer-Reasor, Erica, Symmans, W. Fraser, Tawfik, Ossama, Tripathy, Debasish, Troxell, Megan L., van't Veer, Laura J., Venters, Sara J., Vinh, Tuyethoa, Viscusi, Rebecca K., Wallace, Anne M., Wei, Shi, Wilson, Amy, Yau, Christina, Yee, Douglas, Zeck, Jay C., Osdoit, Marie ^*, van der Noordaa, Marieke, Shad, Sonal, Wei, Jane, de Croze, Diane, Hamy, Anne-Sophie, Laé, Marick, Reyal, Fabien, Sonke, Gabe S, Steenbruggen, Tessa G, van Seijen, Maartje, Wesseling, Jelle, Martín, Miguel, del Monte-Millán, Maria, López-Tarruella, Sara, Boughey, Judy C, Goetz, Matthew P, Hoskin, Tanya, Gould, Rebekah, Valero, Vicente, Edge, Stephen B, Abraham, Jean E, Bartlett, John M S, Caldas, Carlos, Dunn, Janet, Earl, Helena, Hayward, Larry, Hiller, Louise, Provenzano, Elena, Sammut, Stephen-John, Thomas, Jeremy S, Cameron, David, Graham, Ashley, Hall, Peter, Mackintosh, Lorna, Godwin, Andrew K, Schwensen, Kelsey, Sharma, Priyanka, DeMichele, Angela M, Cole, Kimberly, Kim, Mi-Ok, van 't Veer, Laura J, Esserman, Laura J, Symmans, W Fraser

Source: In The Lancet Oncology January 2022 23(1):149-160

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Authors: Pusztai, Lajos, Yau, Christina, Wolf, Denise M., Han, Hyo S., Du, Lili, Wallace, Anne M., String-Reasor, Erica, Boughey, Judy C., Chien, A. Jo, Elias, Anthony D., Beckwith, Heather, Nanda, Rita, Albain, Kathy S., Clark, Amy S., Kemmer, Kathleen, Kalinsky, Kevin, Isaacs, Claudine, Thomas, Alexandra, Shatsky, Rebecca, Helsten, Theresa L., Forero-Torres, Andres, Liu, Minetta C., Brown-Swigart, Lamorna, Petricoin, Emmanuel F., Wulfkuhle, Julia D., Asare, Smita M., Wilson, Amy, Singhrao, Ruby, Sit, Laura, Hirst, Gillian L., Berry, Scott, Sanil, Ashish, Asare, Adam L., Matthews, Jeffrey B., Perlmutter, Jane, Melisko, Michelle, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Yee, Doug, van’t Veer, Laura J., Hylton, Nola M., DeMichele, Angela M., Berry, Donald A., Esserman, Laura J.

Source: In Cancer Cell 12 July 2021 39(7):989-998

Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab

Authors: Demissei, Biniyam G., Adusumalli, Srinath, Hubbard, Rebecca A., Denduluri, Srinivas, Narayan, Vivek, Clark, Amy S., Shah, Payal, Knollman, Hayley, Getz, Kelly D., Aplenc, Richard, Carver, Joseph R., Ky, Bonnie

Source: In JACC: CardioOncology June 2020 2(2):179-189

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A

Authors: Clark, Amy S., Cobain, Erin F., Dayao, Zoneddy, Somerfield, Mark R., DeMichele, Angela, Henry, N. Lynn

Source: JCO oncology practice. 18(12):830-832

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100177477926.0x000001&indx=1&recIds=ETOCvdc_100177477926.0x000001

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Authors: Khoury, Katia, Meisel, Jane L., Yau, Christina, Rugo, Hope S., Nanda, Rita, Davidian, Marie, Tsiatis, Butch, Chien, A. Jo, Wallace, Anne M., Arora, Mili, Rozenblit, Mariya, Hershman, Dawn L., Zimmer, Alexandra, Clark, Amy S., Beckwith, Heather, Elias, Anthony D., Stringer-Reasor, Erica, Boughey, Judy C., Nangia, Chaitali, Vaklavas, Christos, Omene, Coral, Albain, Kathy S., Kalinsky, Kevin M., Isaacs, Claudine, Tseng, Jennifer, Roussos Torres, Evanthia T., Thomas, Brittani, Thomas, Alexandra, Sanford, Amy, Balassanian, Ronald, Ewing, Cheryl, Yeung, Kay, Sauder, Candice, Sanft, Tara, Pusztai, Lajos, Trivedi, Meghna S., Outhaythip, Ashton, Li, Wen, Onishi, Natsuko, Asare, Adam L., Beineke, Philip, Norwood, Peter, Brown-Swigart, Lamorna, Hirst, Gillian L., Matthews, Jeffrey B., Moore, Brian, Fraser Symmans, W., Price, Elissa, Beedle, Carolyn, Perlmutter, Jane, Pohlmann, Paula, Shatsky, Rebecca A., DeMichele, Angela, Yee, Douglas, van ‘t Veer, Laura J., Hylton, Nola M., Esserman, Laura J.

Source: Nature Medicine; December 2024, Vol. 30 Issue: 12 p3728-3736, 9p

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Authors: Shatsky, Rebecca A., Trivedi, Meghna S., Yau, Christina, Nanda, Rita, Rugo, Hope S., Davidian, Marie, Tsiatis, Butch, Wallace, Anne M., Chien, A. Jo, Stringer-Reasor, Erica, Boughey, Judy C., Omene, Coral, Rozenblit, Mariya, Kalinsky, Kevin, Elias, Anthony D., Vaklavas, Christos, Beckwith, Heather, Williams, Nicole, Arora, Mili, Nangia, Chaitali, Roussos Torres, Evanthia T., Thomas, Brittani, Albain, Kathy S., Clark, Amy S., Falkson, Carla, Hershman, Dawn L., Isaacs, Claudine, Thomas, Alexandra, Tseng, Jennifer, Sanford, Amy, Yeung, Kay, Boles, Sarah, Chen, Yunni Yi, Huppert, Laura, Jahan, Nusrat, Parker, Catherine, Giridhar, Karthik, Howard, Frederick M., Blackwood, M. Michele, Sanft, Tara, Li, Wen, Onishi, Natsuko, Asare, Adam L., Beineke, Philip, Norwood, Peter, Brown-Swigart, Lamorna, Hirst, Gillian L., Matthews, Jeffrey B., Moore, Brian, Symmans, W. Fraser, Price, Elissa, Heditsian, Diane, LeStage, Barbara, Perlmutter, Jane, Pohlmann, Paula, DeMichele, Angela, Yee, Douglas, van ’t Veer, Laura J., Hylton, Nola M., Esserman, Laura J.

Source: Nature Medicine; December 2024, Vol. 30 Issue: 12 p3737-3747, 11p

Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience

Authors: Pomponio, Maria K., Burkbauer, Laura, Goldbach, Macy, Nazarian, Susanna M., Xie, Fei, Clark, Amy S., Matro, Jennifer M., Fox, Kevin R., Shulman, Lawrence N., Keele, Luke J., Tchou, Julia

Source: Journal of surgical oncology. 121(3):447-455

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100099785518.0x000001&indx=1&recIds=ETOCvdc_100099785518.0x000001

Heart rate and thermal responses to power yoga

Authors: Schubert, Matthew M., Clark, Amy S., De La Rosa, Annie B., Newcomer, Sean C.

Source: In Complementary Therapies in Clinical Practice August 2018 32:195-199

Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?

Authors: Pomponio, Maria K., Keele, Luke J., Fox, Kevin R., Clark, Amy S., Matro, Jennifer M., Shulman, Lawrence N., Tchou, Julia C.

Source: Breast cancer research and treatment. 177(1):137-143

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100127269645.0x000001&indx=1&recIds=ETOCvdc_100127269645.0x000001

Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy

Authors: Demissei, Biniyam G., Finkelman, Brian S., Hubbard, Rebecca A., Zhang, Liyong, Smith, Amanda M., Sheline, Karyn, McDonald, Caitlin, Narayan, Hari K., Narayan, Vivek, Waxman, Adam J., Domchek, Susan M., DeMichele, Angela, Shah, Payal, Clark, Amy S., Bradbury, Angela R., Carver, Joseph R., Upshaw, Jenica, Armenian, Saro H., Liu, Peter, Ky, Bonnie

Source: Cancer. 125(16):2762-2771

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100085856112.0x000001&indx=1&recIds=ETOCvdc_100085856112.0x000001

The efficacy and safety of hypofractionated radiotherapy with concurrent anti‐HER‐2 therapy following breast‐conserving therapy for breast cancer

Authors: Dreyfuss, Alexandra D., Barsky, Andrew R., Taunk, Neil K., Clark, Amy S., Freedman, Gary M.

Source: Breast journal. 25(6):1097-1103

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100091429844.0x000001&indx=1&recIds=ETOCvdc_100091429844.0x000001

A Quantitative Bias Analysis Approach to Informative Presence Bias in Electronic Health Records.

Authors: Hanxi Zhang, Clark, Amy S., Hubbard, Rebecca A.

Source: Epidemiology; May2024, Vol. 35 Issue 3, p349-358, 10p

A Quantitative Bias Analysis Approach to Informative Presence Bias in Electronic Health Records

Authors: Zhang, Hanxi, Clark, Amy S., Hubbard, Rebecca A.

Source: Epidemiology; May 2024, Vol. 35 Issue: 3 p349-358, 10p

PET oestrogen receptor imaging: ready for the clinic?

Authors: Mankoff, David A, Clark, Amy S

Source: Lancet oncology. 20(4):467-469

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111558404.0x000001&indx=1&recIds=ETOCvdc_100111558404.0x000001

^1^8F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications

Authors: Liao, Geraldine J., Clark, Amy S., Schubert, Erin K., Mankoff, David A.

Source: Journal of nuclear medicine. 57(8):1269-1275

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN607441570&indx=1&recIds=ETOCRN607441570